The preeclamptic women with neurologic complications, including eclampsia (seizures), cortical blindness, and hemorrhagic stroke, had about 3-fold greater tau and glial fibrillary acidic protein (GFAP) compared to preeclamptic women without neurologic complications or pulmonary edema, hemolysis, elevated liver enzymes, and low platelet count (HELLP) [69]. The gene discussed is MAPT; the disease is pulmonary edema.